United States · FDA National Drug Code directory

LATANOPROST

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
70069-421_836e9c6e-15a0-41bd-b3bb-bd864a5fd1bd
Product NDC
70069-421
Form
SOLUTION/ DROPS
Composition / generic term
LATANOPROST
Labeler
Somerset Therapeutics, LLC
Marketing category
ANDA
Marketing start / end (source format)
20191203
Source listing expiry
20271231

Source-listed ingredients

  • LATANOPROST — 50 ug/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BOTTLE in 1 CARTON (70069-421-01) / 2.5 mL in 1 BOTTLE · 70069-421-01
  • 3 BOTTLE in 1 CARTON (70069-421-03) / 2.5 mL in 1 BOTTLE · 70069-421-03

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →